These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10897031)

  • 1. Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate.
    Welsh JS; Howard SP
    Cancer; 2000 Jul; 89(1):226-7. PubMed ID: 10897031
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary leukemia: twice is a coincidence?
    Akerley W
    Cancer; 2000 Feb; 88(3):497-9. PubMed ID: 10649239
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute myelogenous leukemia after exposure to strontium-89 for the treatment of adenocarcinoma of the prostate.
    Kossman SE; Weiss MA
    Cancer; 2000 Feb; 88(3):620-4. PubMed ID: 10649256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloid leukemia incidence following radiation therapy for localized or locally advanced prostate adenocarcinoma.
    Ojha RP; Fischbach LA; Zhou Y; Felini MJ; Singh KP; Thertulien R
    Cancer Epidemiol; 2010 Jun; 34(3):274-8. PubMed ID: 20427255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukaemia followingg strontium-89.
    Prestwich R; Bottomley D
    Clin Oncol (R Coll Radiol); 2003 Oct; 15(7):441. PubMed ID: 14570095
    [No Abstract]   [Full Text] [Related]  

  • 7. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.
    Abdel-Wahab M; Reis IM; Hamilton K
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):58-68. PubMed ID: 18374503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postradiation prostatic sarcoma: de novo carcinogenesis or dedifferentiation of prostatic adenocarcinoma?
    Canfield SE; Gans TH; Unger P; Hall SJ
    Tech Urol; 2001 Dec; 7(4):294-5. PubMed ID: 11763492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute leukemias after treatment with radioiodine for thyroid cancer.
    Roldán Schilling V; Fernández Abellán P; Domínguez Escribano JR; Rivas González C; Mut Barberá E; Calatayud Cendra R
    Haematologica; 1998 Aug; 83(8):767-8. PubMed ID: 9793274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the risks of second cancer formation after radiotherapy to the prostate?
    Goldstraw MA; Payne H; Kirby RS
    BJU Int; 2006 Sep; 98(3):489-91. PubMed ID: 16925740
    [No Abstract]   [Full Text] [Related]  

  • 11. What are the risks of second cancer formation after radiotherapy to the prostate?
    Hellawell GO; Dearden JC
    BJU Int; 2007 Mar; 99(3):698. PubMed ID: 17407526
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostatic carcinosarcoma 15 years after combined external beam radiation and brachytherapy for prostatic adenocarcinoma: a case report.
    Tseng TY; Sevilla DW; Moul JW; Maloney KE
    Prostate Cancer Prostatic Dis; 2006; 9(2):195-7. PubMed ID: 16568146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal squamous cell carcinoma 11 years after brachytherapy for carcinoma of the prostate.
    Yurdakul G; de Reijke TM; Blank LE; Rauws EA
    J Urol; 2003 Jan; 169(1):280. PubMed ID: 12478160
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostatic sarcoma after conservative treatment with brachytherapy for low-risk prostate cancer.
    Domínguez A; Piulats JM; Suárez JF; Condom E; Castells M; Camps N; García Del Muro FX; Franco E
    Acta Oncol; 2013 Aug; 52(6):1215-6. PubMed ID: 23095143
    [No Abstract]   [Full Text] [Related]  

  • 15. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induced second cancers after prostate-cancer radiotherapy: no cause for concern?
    Brenner DJ
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):637-9. PubMed ID: 16751057
    [No Abstract]   [Full Text] [Related]  

  • 17. Epididymitis after prostate brachytherapy.
    Hoffelt SC; Wallner K; Merrick G
    Urology; 2004 Feb; 63(2):293-6. PubMed ID: 14972474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic myeloid leukaemia presenting post-radiotherapy for prostate cancer: further evidence for an immunosurveillance effect.
    Langabeer SE; Burke A; McCarron SL; Kelly J; Carroll P; Browne PV; Conneally E
    Br J Haematol; 2013 Sep; 162(5):708-10. PubMed ID: 23692259
    [No Abstract]   [Full Text] [Related]  

  • 19. Case report of significant bleeding associated with prostate brachytherapy.
    Corcoran AT; Smith RP; Benoit RM
    Can J Urol; 2009 Jun; 16(3):4682-3. PubMed ID: 19497180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].
    Tsuboi K; Kawada H; Suzuki R; Murayama H; Ohmachi K; Nakamura N; Ogawa Y; Ando K
    Rinsho Ketsueki; 2008 Nov; 49(11):1562-5. PubMed ID: 19047789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.